Global Sarcopenia Market Analysis: Key Players, Nutritional Therapeutics vs. Clinical Pipeline & CAGR Growth
Global Sarcopenia Market Size was valued at USD 2.28 billion in 2025 and is projected to grow to USD 5.63 billion by 2034 , with a CAGR of 10.6%. Sarcopenia Market: Overview Sarcopenia Market comprises pharmaceutical treatments, nutritional products, diagnostic technologies, rehabilitation services, and supportive healthcare solutions aimed at addressing sarcopenia, a condition characterized by the progressive loss of skeletal muscle mass, strength, and physical performance. The market includes nutritional supplements containing protein, essential amino acids, and vitamin D, alongside diagnostic tools for assessing muscle strength, body composition, and physical function. It also encompasses clinical assessment services, physical rehabilitation programs, resistance exercise solutions, and emerging drug development initiatives targeting muscle degeneration and related biological pathways. These products and services are relevant to older adults, individuals with chronic diseases...